Authors

Domingo Orozco-Beltran, Universidad Miguel Hernández de Elche
Vicente F. Gil-Guillen, Universidad Miguel Hernández de Elche
Josep Redon, Hospital Clinico Universitario de Valencia
Jose M. Martin-Moreno, Universitat de Valencia, Facultad de Medicina y Odontologia
Vicente Pallares-Carratala, Universidad Jaume I
Jorge Navarro-Perez, Hospital Clinico Universitario de Valencia
Francisco Valls-Roca, Health Center of Beniganim
Carlos Sanchis-Domenech, Health Centre of Algemesi
Antonio Fernandez-Gimenez, ESCARVAL Project
Ana Perez-Navarro, ESCARVAL Project
Vicente Bertomeu-Martinez, Hospital Universitario San Juan
Vicente Bertomeu-Gonzalez, Hospital Universitario San Juan
Alberto Cordero, Hospital Universitario San Juan
Manuel Pascual De La Torre, Biomedical Informatics. Electronic Health Record Office. Conselleria de Sanitat
Jose L. Trillo, Hospital Clinico Universitario de Valencia
Concepcion Carratala-Munuera, Universidad Miguel Hernández de Elche
Salvador Pita-Fernandez, Complejo Hospitalario Universitario Juan Canalejo
Ruth Uso, Conselleria de Sanitat
Ramon Durazo-Arvizu, Stritch School of Medicine
Richard Cooper, Stritch School of Medicine
Gines Sanz, Centro Nacional de Investigaciones Cardiovasculares Carlos III
Jose M. Castellano, Centro Nacional de Investigaciones Cardiovasculares Carlos III
Juan F. Ascaso, Universitat de València
Rafael Carmena, Universitat de València
Maria Tellez-Plaza, Instituto de Investigación Sanitaria Fundación Para la Investigación del Hospital Clínico de Valencia - INCLIVA

Document Type

Article

Publication Date

10-1-2017

Abstract

Introduction: The potential impact of targeting different components of an adverse lipid profile in populations with multiple cardiovascular risk factors is not completely clear. This study aims to assess the association between different components of the standard lipid profile with all-cause mortality and hospitalization due to cardiovascular events in a high-risk population. Methods: This prospective registry included high risk adults over 30 years old free of cardiovascular disease (2008–2012). Diagnosis of hypertension, dyslipidemia or diabetes mellitus was inclusion criterion. Lipid biomarkers were evaluated. Primary endpoints were all-cause mortality and hospital admission due to coronary heart disease or stroke. We estimated adjusted rate ratios (aRR), absolute risk differences and population attributable risk associated with adverse lipid profiles. Results: 51,462 subjects were included with a mean age of 62.6 years (47.6% men). During an average follow-up of 3.2 years, 919 deaths, 1666 hospitalizations for coronary heart disease and 1510 hospitalizations for stroke were recorded. The parameters that showed an increased rate for total mortality, coronary heart disease and stroke hospitalization were, respectively, low HDL-Cholesterol: aRR 1.25, 1.29 and 1.23; high Total/HDL-Cholesterol: aRR 1.22, 1.38 and 1.25; and high Triglycerides/HDL-Cholesterol: aRR 1.21, 1.30, 1.09. The parameters that showed highest population attributable risk (%) were, respectively, low HDL-Cholesterol: 7.70, 11.42, 8.40; high Total/HDL-Cholesterol: 6.55, 12.47, 8.73; and high Triglycerides/HDL-Cholesterol: 8.94, 15.09, 6.92. Conclusions: In a population with cardiovascular risk factors, HDL-cholesterol, Total/HDL-cholesterol and triglycerides/HDL-cholesterol ratios were associated with a higher population attributable risk for cardiovascular disease compared to other common biomarkers.

Publication Source (Journal or Book title)

PLoS ONE

Share

COinS